Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Toos Daemen | M | - |
ViciniVax BV
 ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands.
University of Groningen
| 16 years |
| Cees Griffioen | M | 83 |
University of Groningen
| - |
| Stef G. Kranendijk | M | - |
University of Groningen
| - |
| Robert A. H. van der Meer | M | 75 |
University of Groningen
| 35 years |
| Henk A.T. Chin-Sue | M | 71 |
University of Groningen
| - |
| Klaas Poelstra | M | 60 |
University of Groningen
| - |
| Marnix Pool | M | - |
University of Groningen
| - |
| Janneke Meulenberg | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
| Christopher Hillyer | M | - |
University of Groningen
| 12 years |
| Jacques Wallage | M | 78 |
University of Groningen
| - |
| Wietze Reehoorn | M | 62 |
University of Groningen
| - |
| J. G. van der Linde | F | 67 |
University of Groningen
| - |
| J. M. L. van Engelen | M | 64 |
University of Groningen
| - |
| Hélène Vletter-van Dort | M | 58 |
University of Groningen
| - |
| Ate van der Zee | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | 16 years |
| Femke de Vries | F | 51 |
University of Groningen
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ytsen van der Meer | M | - |
University of Groningen
| 8 years |
| Rutger Mulder | M | - |
University of Groningen
| 5 years |
| Paul Tutein Nolthenius | M | 36 |
University of Groningen
| 6 years |
| Yi Fan Gu | M | - |
University of Groningen
| 5 years |
| Wouter van der Stee | M | - |
University of Groningen
| 6 years |
| Beau-Anne Chilla | F | - |
University of Groningen
| 6 years |
| Alfred N. Nijkerk | M | 59 |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
| Saskia Leenstra | F | - |
University of Groningen
| 4 years |
| MacFarlane Ruaridh | M | - |
University of Groningen
| 3 years |
| Sonia Renoult | F | - |
University of Groningen
| 2 years |
| Tom Schonk | M | - |
University of Groningen
| 4 years |
| Daniël Delodder | M | - |
University of Groningen
| 4 years |
| Bjorn Redmeijer | M | - |
University of Groningen
| 2 years |
| Saskia van den Ende | F | - |
University of Groningen
| 4 years |
| Kristano Reinhart | M | - |
University of Groningen
| 3 years |
| Bas R. Jaspers | M | - |
University of Groningen
| 3 years |
| Lense Koopmans | M | 81 |
University of Groningen
| - |
| Robbert Kloosterman | M | - |
University of Groningen
| 1 years |
| Maurits Dekker | M | - |
University of Groningen
| 4 years |
| Anne van der Voorden | F | - |
University of Groningen
| 4 years |
| Hanneke Moddeman | M | - |
University of Groningen
| 2 years |
| Martijn Kleinbussink | M | - |
University of Groningen
| 4 years |
| Floris van Halder | M | - |
University of Groningen
| 2 years |
| Joost Pieter Boer | M | 36 |
University of Groningen
| 4 years |
| Danielle van Dalfsen | F | - |
University of Groningen
| 3 years |
| Arif Pradana | M | 41 |
University of Groningen
| 3 years |
| Jan C. Wilschut | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
| Sam Tidswell | M | - |
University of Groningen
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 44 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hans Nijman
- Personal Network
